IDEXX > Companion Animal > Education and Events > Diagnostic Edge Newsletter
 
diagnositc edge logo
April 2008 Issue 
In this issue:
•   Surveys: See the results of last month’s coagulation testing survey and take this month’s hypothyroidism survey
•   Education: 12-year-old neutered male rottweiler Tonka has taken a surprising turn for the worse
•   Training and Events: See Webinars, seminars and online training opportunities available this month
•   IDEXX Innovations:
  • Sign up for exclusive Catalyst Dx™ and SNAPshot Dx™ Analyzer communications
  • Faster, easier SNAP® T4 Test
  • SNAP® Feline Triple™ Test coming soon
•   Practice Developer®: New program makes it easier to earn, save and spend your points
•   Suite Stories: An interview with Dr. Craig Davidson of Crestview Animal Clinic, Lincoln University, PA
•   Interactive Challenge: Earn FREE continuing education credit in the United States, Australia and parts of Canada! Answer questions about a regenerative anemia using a peripheral blood film from an EDTA anticoagulated blood specimen from a poodle.
 
Newsletter archive
Subscribe now
Print this page
Customer support is available 24/7 in the U.S. and Canada.
1-800-248-2483
 
IDEXX/EBI equine specialty reference laboratory site now at IDEXX Equine Health
AAHA Advocates Better Care for More Profit

Survey

This month’s survey question

For evaluation of a dog with clinical signs of hypothyroidism, in addition to a CBC with blood film review, chemistry profile and a complete urinalysis, which test(s) are you most likely to use to aid in the diagnosis of hypothyroidism?
 

Look for results from this survey in next month’s issue.

Thank you for responding to our March survey! Here are the results:

March survey results

Coagulation Evaluation

As you can see from the March survey results, the top three areas where Diagnostic Edge respondents are most likely to evaluate coagulation status, including a PT and an aPTT, are for disseminated intravascular coagulation (DIC), known or suspected rodenticide toxicity and to screen for severe systemic disease.

These results emphasize the need to closely monitor coagulation status, including a complete blood cell count and platelets as well as the PT and PTT, in severe disease states that can ultimately lead to DIC, which carries a poor to grave prognosis. Successful treatment and prognostication of DIC also involves judicious monitoring of coagulation status.

Fewer respondents were likely to use coagulation status as a presurgical screen for at-risk patients. Even significantly fewer respondents perform coagulation testing for hereditary bleeding disorders. This could be because the frequency of encountering hereditary bleeding disorders in general veterinary practice, such as Hemophilia A and B, is relatively low. Interpretation must be made with caution because of the relatively low number of responders to the survey.


Education

Featured case study:
12-year-old neutered male rottweiler, Tonka
by Dr. Katie Thompson of the Veterinary Center at Fishhawk, Lithia, Florida

Case Study: Tonka

Detailed history
Tonka was neutered two years ago. He had a history of immune-mediated thrombocytopenia three years ago. Six weeks prior to the emergency presentation, Tonka presented for a routine geriatric wellness evaluation. At that time, a complete blood count (CBC) and chemistry profile were unremarkable, with all results within reference interval limits. A SNAP® 4Dx® Test was negative and Tonka was current on all heartworm, flea/tick and intestinal parasite prophylaxis as well as appropriate vaccines. Other than the presence of a large, slow-growing, lipoma-like mass, his physical examination was also unremarkable. The owners elected surgical removal of the lipoma (confirmed on histopathology) 10 days prior to the current emergency presentation. Tonka’s recovery from surgery was uneventful.

Physical examination
On physical examination, Tonka was pyrexic (T=103.9°F) and in good body condition. He was laterally recumbent and appeared moribund with signs of shock: tachypnea, tachycardia, pale-to-white and mildly icteric mucous membranes and weak and “thready” femoral pulses. Mild splenomegaly was present on abdominal palpation. The surgical incision site from the lipoma removal was clean, dry and intact.

Differential diagnoses
The working clinical differential included splenic neoplasia such as hemangiosarcoma with rupture and secondary hemorrhage, immune-mediated hemolytic anemia (IMHA), ehrlichiosis, leptospirosis, other infectious diseases, lead or other toxicities, trauma, drug hypersensitivity, gastrointestinal ulceration and acute/chronic renal or hepatic failure.

Diagnostic plan
A CBC, complete chemistry profile including electrolytes and a complete urinalysis were performed in order to assess potential primary and secondary organ involvement. Survey radiographs were taken to investigate for possible splenomegaly and/or abdominal hemorrhage. Pending initial findings, a saline agglutination test and abdominocentesis were planned.

Laboratory data

Case study: hematology report

 






Figure 1—100x oil objective field of view of the monolayer of a blood film from a dog, Wright’s stain. Note the numerous spherocytes, the large polychromatophil (center) and the toxic immature (band) neutrophil (lower left).
Case study: figure 1

Erythron—There was a severe, minimally-to-mildly regenerative anemia present. Elevation of MCHC (above the analyzer’s reportable range) supports the likely presence of cell-free hemoglobin due to in vitro or in vivo hemolysis or a combination of both. A minimal-to-mild increase in the absolute reticulocyte count was an objective indicator of bone marrow response to a peripheral demand for erythrocytes/regeneration. Polychromasia noted on the blood film supported the reticulocyte count reported. Other significant morphologic findings included the presence of numerous spherocytes, marked anisocytosis and the presence of occasional nucleated red blood cells. The presence of marked spherocytosis with no other significant poikilocytosis strongly suggested extravascular immune-mediated hemolytic anemia; cause is not identified. Agglutination was suggested during blood film review.

Leukon—The leukon was characterized by a moderate leukocytosis, which was characterized by a neutrophilia, monocytosis and an insignificant basophilia. The neutrophilia and monocytosis supported inflammation, which is commonly seen with intravascular and extravascular hemolytic disease. Review of the blood film revealed moderately toxic neutrophils and a mild left shift, which also support inflammation. The lack of lymphopenia and eosinopenia made glucocorticoid influence (“stress”) unlikely, which is confusing with this clinical presentation where “stress” was quite likely.

Thrombon—Platelet numbers are within reference interval limits; however, the MPV (mean platelet volume) and PDW (platelet distribution width) are higher than typically seen with dog platelets. Normally both the MPV and PDW are less than 18 fL and 18%, respectively. The finding of larger than normal platelets on average (increased MPV) and more variably sized platelets than normal (increased PDW) supported a bone marrow response to a peripheral demand for platelets. Compensated peripheral destruction (possible immune-mediated destruction) or consumption of platelets would be considered but in light of the probable IMHA, immune destruction of platelets is most likely.

Clinical chemistry

Case study: chemistry report

Hepatic panel—The mild increased ALT and ALKP supported minimal hepatocellular injury and possible cholestasis; however, changes are not severe and they most likely represent secondary changes to the severe anemia rather than primary hepatic disease. The minimal increased total bilirubin may represent a false-positive interference from the hemolysis; however, both prehepatic icterus (liver conjugating capacity overwhelmed with bilirubin from the hemolytic disease) and cholestasis must be considered also.

Case study: urinalysis report

Urinalysis—The presence of moderate bilirubinuria in the face of a nonconcentrated urine specific gravity supports possible minimal cholestasis.

Case study: additional testing

Diagnostic summary
The marked spherocytosis with no other significant poikilocytosis was strongly supportive of IMHA. A positive saline agglutination test was additional support. Although no thrombocytopenia was seen, immune mediated destruction of platelets with complete compensation was suggested due to the morphologic evidence for bone marrow response to a peripheral demand for platelets; platelet lifespan was likely decreased.

Therapeutic plan
Initial supportive care included intravenous fluid therapy, three blood transfusions with DEA 1.1 negative packed RBC, azathioprin and prednisolone (slow tapering doses), famotidine, ultra-low-dose aspirin and doxycycline. Serial laboratory data, including complete blood counts and chemistries, were included in the monitoring plan.

Clinical case outcome
Tonka continues to do very well several months after his diagnosis of IMHA on a low
every-other-day dose of prednisolone and azathioprin and judicious monitoring of clinical signs and laboratory values. Serial packed cell volume (PCV) measurements are presented in Figure 2.

Case study: cell volume measurements

Figure 2—Serial packed cell volume (PCV) measurements over the clinical course and subsequent follow-up monitoring.

Case study: clinical tip

When autoagglutination is suggested on microscopic evaluation of the blood film, consider performing a simple in-house saline agglutination test. There are multiple reported ways of performing this assay but a simple method consists of mixing one drop EDTA anticoagulated blood (purple-top tube) with one drop of physiologic (0.9%) saline.

The slide is then examined grossly and microscopically for signs of agglutination. Rouleaux and nonspecific erythrocyte clumping is related to a weak electrostatic surface charge between cells and typically disperses during the dilution process where the
three-dimensional clumping associated with autoagglutination is related to a strong antibody cross-linking between cells and typically remains.

In some cases where there is difficulty differentiating rouleaux from true autoagglutination, a greater dilution with saline may be needed. The following process can be effective: Place a drop of EDTA anticoagulated blood on a glass slide. Place a coverslip over the blood. Place several drops of saline on the slide at the edge of the coverslip. Watch microscopically for cell dispersion or retention of three-dimensional clumping as the saline rushes under the coverslip and dilutes the blood to a much greater degree.

The recommendations contained in Diagnostic Edge educational materials are intended to provide general guidance only. As with any diagnosis or treatment, you should use clinical discretion with each patient based on a complete evaluation of the patient, including history, physical presentation and complete laboratory data. With respect to any drug therapy or monitoring program, you should refer to product inserts for a complete description of dosages, indications, interactions and cautions.

Tell us what you think of this case, or let us know if you have a case that you would like to submit. E-mail us at diagnosticedge@idexx.com to get the process started.


Training and Events

IDEXX Learning Center

The IDEXX Learning Center provides knowledge you can put into practice. Take part in the evolution of animal diagnostics through an ongoing educational partnership with leading veterinarians from across the globe and take advantage of a wide range of education resources, reference materials and events. Visit the IDEXX Learning Center to see a full listing of available Webinars, seminars and online training courses from IDEXX.
 

IDEXX Learning Center Create your own account on the IDEXX Learning Center and see how IDEXX can help you reach your educational goals!


Here are some of the opportunities available this month:

Webinars

See a full listing of webinar opportunities >
 

Online training

See a full listing of online courses >
 

Seminars

See a full listing for seminar opportunities >
 


Product innovations

Take your practice of medicine to the next level

Receive exclusive communications on the revolutionary new Catalyst Dx™ and SNAPshot Dx™ Analyzers

Catalyst Dx and SNAPshot Dx Catalyst Dx SNAPshot Dx

The two newest additions to the IDEXX VetLab® Suite increase your in-house diagnostic capabilities and allow you to offer your patients and clients an increased level of care:
real-time answers at the point of service in just one visit.

Count me in
  • Get updates on these two revolutionary analyzers
  • Hear what other veterinary professionals are saying about them
  • Ask questions and tell us what you think!
  • The Catalyst Dx Chemistry Analyzer offers unmatched speed, efficiency, flexibility and throughput as well as a broad test menu, including 27 individual tests and 6 preloaded test CLIPs.
     
  • The SNAPshot Dx Analyzer allows you to run multiple SNAP tests simultaneously and reads your results automatically, downloading them to patient records.
     

The Catalyst Dx™ and SNAPshot Dx™ Analyzers are integral parts of the IDEXX VetLab® Suite. For more information, visit www.idexx.com/vetlab.


The SNAP® T4 Test just got faster and easier!

Plasma and new workflow for quicker results!

Now you can run plasma on the new SNAP T4 Test. Running plasma eliminates the clotting time necessary for serum samples—with plasma T4 you can have results in just 15 minutes!

SNAP T4

For more information on the SNAP T4, Cortisol and Bile Acids tests or to see how you can get results in 15 minutes, please visit www.idexx.com/snapreader, www.idexx.com/snapshot or call
1-800-355-2896.

*

SNAP T4 and Cortisol devices require 10 minutes and SNAP Bile Acids requires 30 minutes to warm up if not removed from the refrigerator in advance. Devices can be removed from refrigeration up to 5 eight-hour cycle times.


IDEXX to Introduce SNAP® Feline Triple™ Test

Coming soon, the SNAP® Feline Triple™ Test features feline immunodeficiency virus antibody, feline leukemia virus antigen and now, feline heartworm antigen. This three-in-one test for feline infectious diseases introduces a new tool to promote feline health care at no additional cost. The test is highly specific for feline heartworm. SNAP Feline Triple also features optimized sensitivity for FIV and FeLV.

SNAP Feline Triple

SNAP Feline Triple remains the most accurate in-house retrovirus screening tool for kittens and cats that are at-risk or sick, and now offers you the ability to assess adult heartworm infections in your area.

Offer clients better value by testing cats for three high profile diseases in one simple blood draw.

Visit www.idexx.com/snapfelinetriple to sign up for e-mail notification when this exciting new test becomes available.


Practice Developer

The new IDEXX Practice Developer® program is here!

On January 1, 2008, we introduced the new IDEXX Practice Developer program, which features a simplified point calculation and increased opportunities to earn. You can still earn up to 8% on your purchases but now it’s easier for you to earn, save and spend your points. Over the years, many of you have contributed great suggestions as to how we can improve the program. We listened carefully and incorporated your feedback.

IDEXX Practice Developer is a points-based recognition program designed to continually thank you for every purchase, big or small, and to help you save up for diagnostic and management tools that can help grow your practice. We’ve made it as simple as possible for you to make the most of your everyday purchases.

Here’s how it works:

  • You earn points on IDEXX purchases: 1 point = 1 dollar
  • Save them up to invest in diagnostic tools that can help grow your practice
  • Call your IDEXX representative at 1-800-248-2483 to spend points on any IDEXX product or service
  • We track the points for you
  • No membership fees or paperwork

Try our easy point calculator to see how much you can earn.

Already enrolled?
No need to re-enroll in the enhanced program. You’ll be receiving your new statement soon.

Ready to enroll?
Call 1-800-248-2483 or visit the Practice Developer site for more information.


Suite Stories spotlight

Spotlight on Dr. Craig Davidson of Crestview Animal Clinic, Lincoln University, PA

Crestview Animal Clinic has been open for 30 years and is currently a two-veterinarian practice with four veterinary technicians and four office staff. Dr. Davidson, who has been with Crestview for a year and a half, estimates they see about 80 animals a week.

With regard to in-house testing, Dr. Davidson told us, “We’re utilizing in-house testing more frequently now than we did and I think that will continue to be the case. We use it for everything we can.”

WSNAP Feline Triple

“It think it makes a major difference for the owners. That’s the main reason we like to do things in-house. We have access to outside labs, but in-house gives us faster results. It’s nice to do the tests while people wait, otherwise, they sit at home all day worrying. If we can get back to them sooner, it eases their mind and gives them more confidence in what we do.”

“The ability to test in-house also allows us to recommend and follow through immediately on tests like preanesthetic lab work on spays and neuters. We still use outside labs for specialized tests, such as monitoring Phenobarbital, specific liver tests and thyroid profiles.”

“Practices that aren’t taking advantage of in-house testing are missing a big opportunity to adjust their cases and how they handle them on a daily basis. You sleep better at night knowing the answers. It also makes a big difference when you’re working up critical cases. You can make better judgments and know what changes to make on treatment protocols.”

Dr. Davidson’s Story:

Our practice has access to local laboratories with 24-hour test turnaround and free sample pick-ups but we still use our IDEXX VetLab and LaserCyte on a daily basis. One reason can be illustrated using our LaserCyte analyzer.

Recently, an 8-year-old spayed female Yorkie was presented to our clinic to be examined for some skin lesions. Upon examination ecchymoses and petechiae were found on the ventral abdomen. A blood sample was immediately drawn with the owners consent. The blood panel revealed a normal RBC count with a marked thrombocytopenia [platelet count 10 (175-500)], a leukopenia and neutropenia.

Thanks in part to our in-house laboratory, within 15 minutes we were able to complete a history, a preliminary exam and a CBC and begin to educate the owners about the
auto-immune thrombocytopenia. We were able to start appropriate treatment immediately.

This ability instills confidence in our clients but the real payoff occurs in future follow-up visits. The LaserCyte allowed us to confidently and quickly monitor our blood parameters while the client waits and we can then instantly adjust our treatments based on how our patient is doing. Today, our Yorkie is still tapering her prednisone dose but is doing wonderfully and her platelet count has returned to normal.

Telling a client that their pet has a life-threatening condition is very scary and unnerving for them. Giving answers and making therapy decisions quickly instills in the client a sense of control over the situation. Waiting 24 hours, although to us may seem reasonable, makes the clients feel helpless, anxious and confused, and those feelings lead to doubt about their pet’s chances and care.

On a daily basis, veterinarians deal with diagnosed conditions that nevertheless have uncertain outcomes. Our clients’ confidence and trust in our abilities are essential for us to effectively battle these conditions and give their pets the best chance at survival. Our IDEXX lab equipment is one tool that we as veterinarians can use to continue to earn that trust.

To see more stories like Dr. Davidson’s, go to www.suitestories.com. For more information on the IDEXX VetLab® Suite, visit www.idexx.com/vetlab.


interactive challenge

With FREE continuing education credit!*

NOW Approved in the United States, Australia and parts of Canada!

Have you taken advantage of every qualifying Interactive Challenge for FREE continuing education (CE) credits?

Every Interactive Challenge from June 2006 on has each been worth 0.5 continuing education credit in the United States—and you get the credit just for participating! Check out the Diagnostic Edge archive and take any qualifying challenges you may have missed. Don’t let these fun credits slip away!

Questions:

  1. 1. Which of the following morphologic findings in this image is the BEST indicator that this is a regenerative anemia?
  1. Anisocytosis
  2. Spherocytosis
  3. Polychromasia
  4. Howell-Jolly Bodies
  5. Nucleated RBCs (arrows)
  1. Suggest a mechanism for this anemia.

Figure 1. Peripheral blood film from an EDTA anticoagulated blood specimen from an adult poodle with a hematocrit of 8.0%, monolayer of the blood film, 50x objective field of view.
 
interactive challenge

All fields are required for CE credit records.

  1. Which of the following morphologic findings in this image is the BEST indicator that this is a regenerative anemia?
a. Anisocytosis
b. Spherocytosis
c. Polychromasia
d. Howell-Jolly Bodies
e. Nucleated RBCs (arrows)
  1. Suggest a mechanism for this anemia.


Name
Practice Name
AVA number (Australia Only)
Address
City
State/Province
Country/Territory
Postal/ZIP Code
Telephone
E-mail Address
Confirm Your E-mail Address

We respect your privacy. For more information, review our privacy policy.

Please include the e-mail address diagnosticedge@idexx.com in your approved senders list to ensure that your e-mail provider will allow you to receive this confirmation. View instructions on how to do this with the most common e-mail service providers.

Not a Diagnostic Edge subscriber? Subscribe now!

All fields are required for continuing education credit records.

Thanks for taking the Diagnostic Edge Interactive Challenge!

*Each interactive challenge meets the requirements for 0.5 hour of continuing education credit in jurisdictions that recognize AAVSB’s RACE approval, however, participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education.

AAVSB Provider Number 106

Interactive challenges are also approved in Australia for 0.5 AVA Vet Ed Point and from the following Canadian Veterinary Medical Associations: Alberta, Saskatchewan, New Brunswick and Prince Edward Island.

All ®/TM marks are owned by IDEXX Laboratories, Inc. or its affiliates in the United States and/or other countries.


This symbol indicates PDF-formatted materials. To view, you may need to download a free copy of Adobe® Reader® software.

 
© 2008 IDEXX Laboratories, Inc.
All rights reserved.